![](/img/cover-not-exists.png)
A Phase IB Clinical Study with 18F-Fdg-Pet Response Evaluation of the Combination of Temsirolimus (T) And Pegylated Liposomal Doxorubicin (PLD) in Breast, Endometrial and Ovarian Cancer
Sonderen, M.J., Desar, I.M.E., De Geus-Oei, L., van der Graaf, W.T.A., Oyen, W.J.G., Ottevanger, P.B., van Herpen, C.M.L.Volume:
23
Journal:
Annals of Oncology
DOI:
10.1016/s0923-7534(20)33021-0
Date:
September, 2012
File:
PDF, 64 KB
2012